<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00976027</url>
  </required_header>
  <id_info>
    <org_study_id>FIM07</org_study_id>
    <secondary_id>UTN: U1111-1111-4478</secondary_id>
    <nct_id>NCT00976027</nct_id>
  </id_info>
  <brief_title>Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older</brief_title>
  <official_title>Multi-Year Efficacy Study of Fluzone High-Dose Trivalent Vaccine Compared With Fluzone® Vaccine In Adults ≥ 65 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the efficacy of Fluzone High Dose vaccine and that of
      Fluzone® vaccine in the elderly.

      Primary objective:

      To measure the efficacy of the vaccine, defined as the prevention of laboratory-confirmed
      influenza caused by viral types/subtypes that are antigenically similar to those contained in
      the respective annual vaccine formulations.

      Secondary objectives:

        -  To compare the clinical efficacy of Fluzone High Dose vaccine with that of Fluzone®
           vaccine in elderly adults, with respect to laboratory-confirmed influenza illness caused
           by any type or subtype of influenza virus.

        -  To compare the clinical efficacy of Fluzone High Dose vaccine with that of Fluzone®
           vaccine in elderly adults, in preventing culture-confirmed influenza illness caused by
           viral types/subtypes antigenically similar to those contained in the respective annual
           vaccine formulations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The occurrence of influenza-like illness (ILI) will be determined in elderly participants
      vaccinated with either Fluzone High Dose or Fluzone® vaccine.

      The presence of influenza virus in the respiratory tract of vaccinated individuals with ILI
      will be confirmed by two methods.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No safety concerns, study terminated due to lack of primary endpoint cases in 2009-2010 Flu
    season (coincided with H1N1 Pandemic) Subjects followed per-protocol
  </why_stopped>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of Fluzone High Dose Relative to Fluzone in the Prevention of Laboratory Confirmed Influenza Caused by Viral Types and Subtypes That Are Antigenically Similar to Those Contained in the Respective Annual Vaccine Formulations.</measure>
    <time_frame>Day 0 (pre-vaccination) up to Year 1 post-vaccination</time_frame>
    <description>The presence (and specific identification) of influenza virus in the respiratory tract of vaccinated individuals with influenza like illness (ILI) was confirmed by tissue culture (for infectious virus) and molecular techniques (polymerase chain reaction based assays), with results reported for cases cause by any viral type or subtype.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Number of Participants Reporting Events Associated With All Cases of Protocol Defined Influenza-Like Illness (ILI)</measure>
    <time_frame>Day 0 (pre-vaccination) up to the end of the influenza season</time_frame>
    <description>Events associated with Protocol defined influenza-like Illnesses (ILI) were defined as pneumonia, new onset or exacerbation of pre-existing cardio respiratory conditions, health care visits, and medication use (including nonsteroidal anti-inflammatory drugs, NSAIDs).</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants Reporting Events Associated With All Cases of CDC Defined Influenza-Like Illness (ILI)</measure>
    <time_frame>Day 14 (post-vaccination) up to 12 Months post-vaccination</time_frame>
    <description>Events associated with CDC defined influenza-like Illnesses (ILI) were defined as pneumonia, new onset or exacerbation of pre existing cardio respiratory conditions, health care visits, and medication use (including nonsteroidal anti-inflammatory drugs, NSAIDs).</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants Reporting Adverse Events of Special Interest (AESIs) and Serious Adverse Events Post-vaccination With Either Fluzone High-Dose and Fluzone</measure>
    <time_frame>Day 0 before vaccination to Day 180 after vaccination</time_frame>
    <description>Adverse events of special interest: new onset of Guillain Barre Syndrome (GBS), Bell's Palsy, encephalitis or myelitis, optic neuritis, Stevens Johnson Syndrome, and toxic epidermal necrolysis</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9172</enrollment>
  <condition>Influenza</condition>
  <arm_group>
    <arm_group_label>Fluzone® High Dose Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluzone® Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Trivalent inactivated influenza vaccine High Dose</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Fluzone® High Dose Group</arm_group_label>
    <other_name>Fluzone® High Dose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Trivalent inactivated influenza vaccine</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Fluzone® Group</arm_group_label>
    <other_name>Fluzone®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria :

          -  Aged ≥ 65 years on the day of vaccination

          -  Informed consent form signed and dated.

          -  Able to attend all scheduled visits and to comply with all trial procedures.

        Exclusion Criteria :

          -  Participation in another interventional clinical trial investigating a vaccine, drug,
             medical device, herbal supplement, or a medical procedure in the 4 weeks preceding the
             trial vaccination or planned participation in another clinical trial investigating a
             vaccine, drug, medical device, herbal supplement, or a medical procedure during each
             year of participation in the study trial.

          -  Vaccination against influenza in the 6 months preceding the trial vaccination.

          -  Systemic hypersensitivity to eggs, chicken proteins, or any of the vaccine components,
             or a history of a life-threatening reaction to Fluzone vaccine or to a vaccine
             containing any of the same substances.

          -  Personal history of Guillain-Barré syndrome.

          -  Dementia or any other cognitive condition at a stage that could interfere with
             following the trial procedures.

          -  Thrombocytopenia, bleeding disorder, or anticoagulation therapy contraindicating
             intramuscular (IM) vaccination.

          -  Known or suspected human immunodeficiency virus (HIV), Hepatitis B surface antigen
             (HBsAg), or Hepatitis C seropositivity.

          -  Alcohol abuse or drug addiction that could interfere with the subject's ability to
             comply with trial procedures.

          -  Subject deprived of freedom by an administrative or court order, or in an emergency
             setting, or hospitalized without his/her consent.

          -  Bedridden subjects.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi Pasteur Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85283</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95831</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milford</city>
        <state>Connecticut</state>
        <zip>06460</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ridgefield</city>
        <state>Connecticut</state>
        <zip>06877</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Celebration</city>
        <state>Florida</state>
        <zip>34747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Crystal River</city>
        <state>Florida</state>
        <zip>34429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cutler Bay</city>
        <state>Florida</state>
        <zip>33189</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Deerfield Beach</city>
        <state>Florida</state>
        <zip>33442</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Inverness</city>
        <state>Florida</state>
        <zip>34452</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32935</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pinellas Park</city>
        <state>Florida</state>
        <zip>33781</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dubuque</city>
        <state>Iowa</state>
        <zip>52002</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arkansas City</city>
        <state>Kansas</state>
        <zip>67005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lenexa</city>
        <state>Kansas</state>
        <zip>66219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexena</city>
        <state>Kansas</state>
        <zip>66215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Prairie Village</city>
        <state>Kansas</state>
        <zip>66206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elkridge</city>
        <state>Maryland</state>
        <zip>21075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenbelt</city>
        <state>Maryland</state>
        <zip>20770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chaska</city>
        <state>Minnesota</state>
        <zip>55318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44311</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <zip>73069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Downingtown</city>
        <state>Pennsylvania</state>
        <zip>19335</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jefferson Hills</city>
        <state>Pennsylvania</state>
        <zip>15025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Penndel</city>
        <state>Pennsylvania</state>
        <zip>19047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Upper St Clair</city>
        <state>Pennsylvania</state>
        <zip>15241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clinton</city>
        <state>South Carolina</state>
        <zip>29325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goose Creek</city>
        <state>South Carolina</state>
        <zip>29445</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <zip>22401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <zip>23185</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lakewood</city>
        <state>Washington</state>
        <zip>98499</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Juan</city>
        <zip>00918</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toa Baja</city>
        <zip>00949</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.sanofipasteur.com</url>
  </link>
  <link>
    <url>http://www.sanofiaventis.com</url>
  </link>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2009</study_first_submitted>
  <study_first_submitted_qc>September 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2009</study_first_posted>
  <results_first_submitted>June 19, 2012</results_first_submitted>
  <results_first_submitted_qc>June 19, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 25, 2012</results_first_posted>
  <last_update_submitted>July 24, 2012</last_update_submitted>
  <last_update_submitted_qc>July 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Influenza</keyword>
  <keyword>Respiratory Tract Infections</keyword>
  <keyword>Influenza-like illness</keyword>
  <keyword>Elderly</keyword>
  <keyword>Fluzone®</keyword>
  <keyword>Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled in the study from 22 September 2009 to 07 November 2009 at 99 clinical centers in the US.</recruitment_details>
      <pre_assignment_details>A total of 9158 of the 9172 participants that were randomized were vaccinated, evaluated, and reported in this report.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Fluzone® High Dose</title>
          <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
        </group>
        <group group_id="P2">
          <title>Fluzone®</title>
          <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6108"/>
                <participants group_id="P2" count="3050"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5697"/>
                <participants group_id="P2" count="2835"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="411"/>
                <participants group_id="P2" count="215"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Serious Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="208"/>
                <participants group_id="P2" count="103"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
                <participants group_id="P2" count="66"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fluzone® High Dose</title>
          <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
        </group>
        <group group_id="B2">
          <title>Fluzone®</title>
          <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6108"/>
            <count group_id="B2" value="3050"/>
            <count group_id="B3" value="9158"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6108"/>
                    <measurement group_id="B2" value="3050"/>
                    <measurement group_id="B3" value="9158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.8" spread="6.0"/>
                    <measurement group_id="B2" value="72.8" spread="5.9"/>
                    <measurement group_id="B3" value="72.8" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3268"/>
                    <measurement group_id="B2" value="1647"/>
                    <measurement group_id="B3" value="4915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2840"/>
                    <measurement group_id="B2" value="1403"/>
                    <measurement group_id="B3" value="4243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6108"/>
                    <measurement group_id="B2" value="3050"/>
                    <measurement group_id="B3" value="9158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Efficacy of Fluzone High Dose Relative to Fluzone in the Prevention of Laboratory Confirmed Influenza Caused by Viral Types and Subtypes That Are Antigenically Similar to Those Contained in the Respective Annual Vaccine Formulations.</title>
        <description>The presence (and specific identification) of influenza virus in the respiratory tract of vaccinated individuals with influenza like illness (ILI) was confirmed by tissue culture (for infectious virus) and molecular techniques (polymerase chain reaction based assays), with results reported for cases cause by any viral type or subtype.</description>
        <time_frame>Day 0 (pre-vaccination) up to Year 1 post-vaccination</time_frame>
        <population>Efficacy was assessed in all participants who met all study inclusion criteria and none of the exclusion criteria, received the vaccine to which they were randomized, and had no protocol violations that might have interfered with evaluation of primary endpoints (Per Protocol Analysis Set).</population>
        <group_list>
          <group group_id="O1">
            <title>Fluzone® High Dose</title>
            <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
          </group>
          <group group_id="O2">
            <title>Fluzone®</title>
            <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
          </group>
        </group_list>
        <measure>
          <title>Efficacy of Fluzone High Dose Relative to Fluzone in the Prevention of Laboratory Confirmed Influenza Caused by Viral Types and Subtypes That Are Antigenically Similar to Those Contained in the Respective Annual Vaccine Formulations.</title>
          <description>The presence (and specific identification) of influenza virus in the respiratory tract of vaccinated individuals with influenza like illness (ILI) was confirmed by tissue culture (for infectious virus) and molecular techniques (polymerase chain reaction based assays), with results reported for cases cause by any viral type or subtype.</description>
          <population>Efficacy was assessed in all participants who met all study inclusion criteria and none of the exclusion criteria, received the vaccine to which they were randomized, and had no protocol violations that might have interfered with evaluation of primary endpoints (Per Protocol Analysis Set).</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6013"/>
                <count group_id="O2" value="3008"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Laboratory Confirmed Cases of ILI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Culture Confirmed Cases of ILI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCR Confirmed Cases of ILI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Reporting Events Associated With All Cases of Protocol Defined Influenza-Like Illness (ILI)</title>
        <description>Events associated with Protocol defined influenza-like Illnesses (ILI) were defined as pneumonia, new onset or exacerbation of pre-existing cardio respiratory conditions, health care visits, and medication use (including nonsteroidal anti-inflammatory drugs, NSAIDs).</description>
        <time_frame>Day 0 (pre-vaccination) up to the end of the influenza season</time_frame>
        <population>The occurrence of events associated with ILI was assessed in all participants who met all study inclusion and exclusion criteria, received the vaccine to which they were randomized, and had no protocol violations that might have interfered with evaluation of primary endpoints (Per-Protocol Analysis Set).</population>
        <group_list>
          <group group_id="O1">
            <title>Fluzone® High Dose</title>
            <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
          </group>
          <group group_id="O2">
            <title>Fluzone®</title>
            <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Events Associated With All Cases of Protocol Defined Influenza-Like Illness (ILI)</title>
          <description>Events associated with Protocol defined influenza-like Illnesses (ILI) were defined as pneumonia, new onset or exacerbation of pre-existing cardio respiratory conditions, health care visits, and medication use (including nonsteroidal anti-inflammatory drugs, NSAIDs).</description>
          <population>The occurrence of events associated with ILI was assessed in all participants who met all study inclusion and exclusion criteria, received the vaccine to which they were randomized, and had no protocol violations that might have interfered with evaluation of primary endpoints (Per-Protocol Analysis Set).</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6013"/>
                <count group_id="O2" value="3008"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pneumonia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardio Respiratory Conditions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Health Care Visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="478"/>
                    <measurement group_id="O2" value="245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emergency Room Visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non Routine Medical Office Visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="439"/>
                    <measurement group_id="O2" value="226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Medication Use (Taken or Prescribed)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="781"/>
                    <measurement group_id="O2" value="402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antipyretics, NSAIDs, Analgesics Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="552"/>
                    <measurement group_id="O2" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antiviral Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antibiotic Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="374"/>
                    <measurement group_id="O2" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Reporting Events Associated With All Cases of CDC Defined Influenza-Like Illness (ILI)</title>
        <description>Events associated with CDC defined influenza-like Illnesses (ILI) were defined as pneumonia, new onset or exacerbation of pre existing cardio respiratory conditions, health care visits, and medication use (including nonsteroidal anti-inflammatory drugs, NSAIDs).</description>
        <time_frame>Day 14 (post-vaccination) up to 12 Months post-vaccination</time_frame>
        <population>The occurrence of events associated with CDC defined ILI was assessed in all participants who met all study inclusion and exclusion criteria, received the vaccine to which they were randomized, and had no protocol violations that might have interfered with evaluation of primary endpoints (Per-Protocol Analysis Set).</population>
        <group_list>
          <group group_id="O1">
            <title>Fluzone® High Dose</title>
            <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
          </group>
          <group group_id="O2">
            <title>Fluzone®</title>
            <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Events Associated With All Cases of CDC Defined Influenza-Like Illness (ILI)</title>
          <description>Events associated with CDC defined influenza-like Illnesses (ILI) were defined as pneumonia, new onset or exacerbation of pre existing cardio respiratory conditions, health care visits, and medication use (including nonsteroidal anti-inflammatory drugs, NSAIDs).</description>
          <population>The occurrence of events associated with CDC defined ILI was assessed in all participants who met all study inclusion and exclusion criteria, received the vaccine to which they were randomized, and had no protocol violations that might have interfered with evaluation of primary endpoints (Per-Protocol Analysis Set).</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6013"/>
                <count group_id="O2" value="3008"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pneumonia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Onset or Exacerbation of Cardio Respiratory</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Health Care Visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145"/>
                    <measurement group_id="O2" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emergency Room Visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non Routine Medical Office Visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                    <measurement group_id="O2" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Medication Use (Taken or Prescribed)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="220"/>
                    <measurement group_id="O2" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antipyretics, NSAIDs, Analgesics Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153"/>
                    <measurement group_id="O2" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antiviral Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antibiotic Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123"/>
                    <measurement group_id="O2" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Reporting Adverse Events of Special Interest (AESIs) and Serious Adverse Events Post-vaccination With Either Fluzone High-Dose and Fluzone</title>
        <description>Adverse events of special interest: new onset of Guillain Barre Syndrome (GBS), Bell's Palsy, encephalitis or myelitis, optic neuritis, Stevens Johnson Syndrome, and toxic epidermal necrolysis</description>
        <time_frame>Day 0 before vaccination to Day 180 after vaccination</time_frame>
        <population>Adverse events of special interest were assessed in all participants who received study vaccine (Full Analysis Set).</population>
        <group_list>
          <group group_id="O1">
            <title>Fluzone® High Dose</title>
            <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
          </group>
          <group group_id="O2">
            <title>Fluzone®</title>
            <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Adverse Events of Special Interest (AESIs) and Serious Adverse Events Post-vaccination With Either Fluzone High-Dose and Fluzone</title>
          <description>Adverse events of special interest: new onset of Guillain Barre Syndrome (GBS), Bell's Palsy, encephalitis or myelitis, optic neuritis, Stevens Johnson Syndrome, and toxic epidermal necrolysis</description>
          <population>Adverse events of special interest were assessed in all participants who received study vaccine (Full Analysis Set).</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6108"/>
                <count group_id="O2" value="3008"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Serious Adverse Events (SAE)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="493"/>
                    <measurement group_id="O2" value="236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Guillain Barre Syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bell's Palsy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Encephalitis or Myelitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Optic Neuritis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stevens Johnson Syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxic Epidermal Necrolysis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SAE Leading to Study Discontinuation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Related SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Related SAE Leading to Study Discontinuation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events data were collected from Day 0 (post-vaccination) up to 8 months post-vaccination.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Fluzone® High Dose</title>
          <description>All participants received a single dose of Fluzone High Dose vaccine on Day 0.</description>
        </group>
        <group group_id="E2">
          <title>Fluzone®</title>
          <description>All subjects received a single dose of Fluzone vaccine on Day 0.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="493" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="236" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Aortic Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block First Degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Second Degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Coronary Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ischaemic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Mitral Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Sick Sinus Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous Malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Atrial Septal Defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Colitis Ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Colitis Ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diverticular Perforation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diverticulitis Intestinal Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Faeces Discolored</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hiatus Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ileus Paralytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intestinal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intra Abdominal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Large Intestine Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Obstruction Gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Oesophageal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Oesophageal Ulcer Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pancreatitis Relapsing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Rectal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Reflux Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Spigelian Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Swollen Tongue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse Drug Reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Catheter Site Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hernia Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Influenza Like Illness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Non Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Actinomycotic pulmonary infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Application site cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Biliary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Septic arthritis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Urinary tract infection enterococcal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Urinary tract infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Klebsiella infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Perineal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Back injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Burns second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ilium fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Sternal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Back disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Spinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Adenoid cystic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intraocular melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Large cell lung cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer stage III</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Paget's disease of the breast</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Splenic marginal zone lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Splenic neoplasm malignancy unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Testis cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Thymoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Drug withdrawal convulsions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Myelitis transverse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Colectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Shoulder arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Femoral artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Ischaemic limb pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
              <event>
                <sub_title>Vascular rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5.00</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6108"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3050"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was terminated due to lack of primary endpoint cases in 2009-2010 influenza season (coincided with the H1N1 Pandemic). There were no safety concerns; enrolled subjects were followed per-protocol.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Medical Director</name_or_title>
      <organization>Sanofi Pasteur Inc.</organization>
      <email>RegistryContactUs@sanofipasteur.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

